| ARIIX | CSFZX | ARIIX / CSFZX | |
| Total Expense Ratio | 0.79 | 0.84 | 94% |
| Annual Report Gross Expense Ratio | 0.79 | 0.84 | 94% |
| Fund Existence | 29 years | 12 years | - |
| Gain YTD | 5.919 | 6.326 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 180M | 2.3B | 8% |
| Annual Yield % from dividends | 4.08 | 3.27 | 125% |
| Returns for 1 year | 5.34 | 5.45 | 98% |
| Returns for 3 years | 32.67 | 28.90 | 113% |
| Returns for 5 years | 1.55 | 4.43 | 35% |
| Returns for 10 years | 45.98 | 48.24 | 95% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BULZ | 39.42 | 0.70 | +1.81% |
| MicroSectors™ Slct FANG Inn 3X Lvgd ETNs | |||
| ONOF | 40.81 | 0.43 | +1.06% |
| Global X Adaptive US Risk Management ETF | |||
| PBAP | 31.49 | 0.07 | +0.22% |
| PGIM S&P 500 Buffer 20 ETF - Apr | |||
| OND | 33.45 | N/A | N/A |
| ProShares On-Demand ETF | |||
| LABU | 261.30 | -4.70 | -1.77% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||